Top Strike Resources Corp. (the “Corporation”) (CSE:VENI) is pleased to announce: (i) the completion of an initial tranche of its previously announced non-brokered private placement of units (“Units”) of the Corporation for gross proceeds of $5.6 million (the “Private Placement”); (ii) the completion of an initial tranche of its previously announced non-brokered private placement of insider units (“Insider Units”) of the Corporation for additional gross proceeds of $1.6 million (the “Insider Private Placement”, and together with the Private Placement, the “Private Placements”); (iii) the resignation of the current board of directors and management team of the Corporation and the concurrent appointment of a new management team (the “New Management Team”) and board of directors (the “New Board”); and (iv) the delisting of the common shares of the Corporation (“Common Shares”) from the NEX Board of the TSX Venture Exchange and the concurrent listing of the Common Shares on the facilities of the Canadian Securities Exchange (the “CSE”) (collectively, the “Transactions”). The Common Shares commenced trading under the ticker symbol “VENI” on the CSE today.

The Transactions have transitioned the Corporation from an oil and gas issuer to a merchant capital firm, rebranded as “Vencanna Ventures Inc.”. The recapitalized Corporation aims to be a go-to capital provider for early-stage global cannabis initiatives with an emphasis on state compliant opportunities in limited licensed jurisdictions in the United States. We look to provide investors with a diversified, high-growth, cannabis investment strategy through strategic investments focused through-out the value chain (cultivation, processing and distribution, and including ancillary businesses). A listing statement dated September 20, 2018 (the “Listing Statement”) with information about the Corporation and the Transactions, prepared in accordance with the policies of the CSE, is available under the Corporation’s profile on SEDAR at

Private Placement and Insider Private Placement

Pursuant to the initial tranches of the Private Placements, the Corporation raised aggregate gross proceeds of $7.2 million. In order to capitalize on further demand, the New Management Team expects to complete second tranches of the Private Placement and the Insider Private Placement on or before October 12, 2018.

Pursuant to the Private Placement, the Corporation issued to subscribers an aggregate of 93,169,642 Units at a price of $0.06 per Unit for aggregate gross proceeds of $5.6 million. Each Unit is comprised of one Common Share and one-half of one Common Share purchase warrant (a “Warrant”). Each Warrant entitles the holder thereof to purchase one Common Share at a price of $0.09 per Common Share until September 24, 2021. Provided that the average trading price of the Common Shares is equal to or exceeds $0.14 for any consecutive 20-day trading period following September 24, 2019, the Corporation will be entitled to accelerate the expiry date of the Warrants.

Pursuant to the Insider Private Placement, the Corporation issued to the New Management, together with additional subscribers identified by the New Management, an aggregate of 31,497,766 Insider Units at a price of $0.05 per Insider Unit for aggregate gross proceeds of $1.6 million, representing an upsize of $0.1 million from the previous announcement. Each Insider Unit is comprised of one Common Share and one Common Share purchase warrant (an “Insider Warrant”). Each Insider Warrant entitles the holder thereof to purchase one Common Share at a price of $0.06 per Common Share until September 24, 2023, provided that if the Common Shares are either: (i) listed on the facilities of a stock exchange other than the CSE; or (ii) acquired for cash or for the securities of a public company not listed on the facilities of the CSE, then each Insider Warrant shall be exercisable for two Common Shares at a price of $0.06 per Common Share.

Pursuant to applicable securities laws, all securities issued pursuant to the Private Placements are subject to a hold period until January 25, 2019.

Following completion of the Transactions, and after taking into account transaction and financing costs, the recapitalized Corporation has a net cash position of approximately $6.5 million. The New Management Team intends to use the net proceeds from the Private Placements to execute on an international cannabis-focused investment strategy with an emphasis on state compliant opportunities in the United States. Please refer to the Listing Statement for additional details about the Corporation’s new corporate strategy.

New Management Team and New Board

Contemporaneous with the closing of the Private Placement, the previously announced appointment of the New Management Team and New Board was completed and the former board of directors and management team of the Corporation resigned. The New Management Team is led by David McGorman as Chief Executive Officer and a director, Jon Sharun, as Executive Director and a director, Jason Ewasuik as Vice President, Originations and Mike Tanasichuk as Chief Financial Officer, with Sony Gill serving as Corporate Secretary. Joining Messrs. McGorman and Sharun on the New Board are Matt Christopherson, Alan Gertner, Dr. Inbar Maymon-Pomeranchik and W. Scott McGregor. Trent Woloveck will serve on the advisory board of the Corporation.

The New Management Team has been extremely active in the legal cannabis sector; actively investing in Canada and the United States and having developed a deep network of contacts within the legal cannabis sector in North America and Europe. The New Management Team has significant investment banking and direct investing experience, and are skilled at identifying, evaluating and adding value to start-up companies.

The members of the New Board have strong track records, distinguished careers and have held prominent lead positions within a range of successful companies, including in the cannabis sector. Their combined experience and expertise will provide the New Management Team with invaluable advice, guidance and mentorship.

The Corporation also announces that, pursuant to the terms and conditions of its stock option plan, it has granted an aggregate of 12,466,740 stock options to purchase Common Shares to the New Management Team, New Board and employees of the Corporation. The options expire five years from the date of grant and are exercisable at a price of $0.06 per Common Share. The options vest as to one third on the grant date and one third on each of the first and second anniversaries of the grant date.

About the Corporation

The Corporation’s recapitalized corporate structure will allow the Corporation to execute on its international cannabis-focused investment strategy as “Vencanna Ventures Inc.”.

It is anticipated that the shareholders of the Corporation will be asked to approve a change of the Corporation’s name to “Vencanna Ventures Inc.” at a special meeting called for such purpose.

Further information on the Corporation and the Transactions are provided in the Listing Statement which has been filed on SEDAR.

For further information regarding this news release, please contact:

David McGorman

Chief Executive Officer and Director

Phone: (403) 351-1779

Jason Ewasuik

Vice President, Originations

Phone: (403) 992-9676

Top Strike Resources Corp.

Suite 300, 407 – 3rd Street S.W.

Calgary, AB T2P 4Z2

Forward-Looking Statements

This news release may include forward-looking statements including opinions, assumptions, estimates, the New Management Team’s assessment of future plans and investment strategy, and, more particularly, statements concerning the completion of the Private Placements, future tranches of the Private Placements, the business plan of the Corporation, the anticipated benefits thereof and the value expected to be provided by the New Management Team to investors in the Corporation, the proposed change of name of the Corporation and use of proceeds of the Private Placements, including future global cannabis investments. When used in this document, the words “will,” “anticipate,” “believe,” “estimate,” “expect,” “intent,” “may,” “project,” “should,” and similar expressions are intended to be among the statements that identify forward-looking statements. The forward-looking statements are founded on the basis of expectations and assumptions made by the Corporation which include, but are not limited to, the timing of the receipt of the required regulatory and third party approvals, the future operations of, and transactions completed by, the Corporation as well as the satisfaction of other conditions pertaining to the completion of the Private Placements. Forward-looking statements are subject to a wide range of risks and uncertainties, and although the Corporation believes that the expectations represented by such forward-looking statements are reasonable, there can be no assurance that such expectations will be realized.

Any number of important factors could cause actual results to differ materially from those in the forward-looking statements including, but not limited to, regulatory and third party approvals not being obtained in the manner or timing anticipated by the Corporation, changes to global cannabis laws, how the developing U.S. legal regime will impact the cannabis industry, the ability to implement corporate strategies and the Corporation’s investment strategy, the state of domestic capital markets, the ability to obtain financing, changes in general market conditions and other factors more fully described from time to time in the reports and filings made by the Corporation with securities regulatory authorities. Additional information regarding other risks and uncertainties relating to the Corporation are contained under the heading “Risk Factors” in the Listing Statement dated September 20, 2018, filed on SEDAR at

Except as required by applicable laws, the Corporation does not undertake any obligation to publicly update or revise any forward-looking statements.

Investors are cautioned that, except as disclosed in the Listing Statement, any information released or received with respect to the Transactions may not be accurate or complete and should not be relied upon.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this news release.


Centurion to acquire a Disruptive Water-Soluble Cannabinoid Technology Platform Delivering Rapid Onset, Increased Bioavailability, Premium Taste Profiles and Highly Competitive Cost Structure

Centurion Minerals Ltd. (TSXV: CTN) (FSE: XJCB) (“Centurion” or the “Company”) is pleased to announce that it has entered into an Amalgamation Agreement dated February 17, 2021 (the “Agreement”), with HAI Beverages Inc. (“HAI”), whereby Centurion will acquire 100% of the outstanding shares and assets of a wholly-owned subsidiary of HAI (“NewHAI) in exchange for common shares of Centurion (the “Acquisition” or “Transaction”). NewHAI holds all material assets of HAI and the Acquisition will constitute a reverse take-over (“RTO”) of the Company.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less